Orale leveringsvaccins marktomvang, aandeel, groei en industrieanalyse, per type (rotavirusvaccin, cholera -vaccin, orale poliovaccin), per toepassing (openbaar en privé) en regionale voorspelling tot 2031.

Gedetailleerde TOC van Global Oral Delivery Vaccines Market Research Report 2024 (Status and Outlook)

Inhoudstabel
1 Onderzoeksmethodologie en statistische scope
1.1 Marktdefinitie en statistische reikwijdte van orale leveringsvaccins
1.2 Belangrijkste marktsegmenten
1.2.1 Mondelinge levering vaccins segment door type
1.2.2 Oral levering vaccins segment door applicatie
1.3 METHODOLIES
1.3.1 BRECTES
Uitbreiding en gegevens triangulatie
1.3.4 BASE JAAR
1.3.5 Rapportnumpties en voorbehouden
2 Marktvaccins Markt Vaccins Markt Overzicht
2.1 Global Market Overzicht
2.1.1 Wereldwijde orale levering Vaccins Market Size (M USD) Schattingen en voorspelling (2019-2030) 2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oral Delivery Vaccines Market Competitive Landscape
3.1 Global Oral Delivery Vaccines Sales by Manufacturers (2019-2024)
3.2 Global Oral Delivery Vaccines Revenue Market Share by Manufacturers (2019-2024)
3.3 Oral Delivery Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oral Delivery Vaccines Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oral Delivery Vaccines Sales Sites, Area Served, Product Type
3.6 Oral Delivery Vaccines Market Competitive Situation and Trends
3.6.1 Oral Delivery Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oral Delivery Vaccines Players Market Share by Inkomsten
3.6.3 Fusies en overnames, uitbreiding
4 mondelinge levering vaccins industriële ketenanalyse
4.1 orale levering vaccins industrie ketenanalyse
4.2 Marktoverzicht van belangrijke grondstoffen
4.3 Midstroom marktanalyse
4.4 Customer -analyse van de klant
5 de ontwikkeling en dynamiek van orale levering Vaccins
5.1. Factoren
5.3 Marktuitdagingen
5.4 Marktbeperkingen
5.5 Industrie Nieuws
5.5.1 Nieuwe productontwikkelingen
5.5.2 Fusies en acquisities
5.5.5 Uitbreidingen
5.5.4 samenwerking/aanbodcontracten
5.6 Industrie beleid
6 orale levering Vaccins Markt Segmentatie door type
6.1 evaluatiematrix (Type)
6.2 Wereldwijde orale levering Vaccins Verkoopmarktaandeel per type (2019-2024)
6.3 Wereldwijde orale levering Vaccins Marktgrootte Marktaandeel per type (2019-2024)
6.4 Wereldwijde orale leveringsvaccins Prijs per type (2019-2024)
7 orale levering vaccins Markt Segmenteren door applicatie
7.1 evaluatiematrix van segmentmarktmarkt) Oral Delivery Vaccines Market Sales by Application (2019-2024)
7.3 Global Oral Delivery Vaccines Market Size (M USD) by Application (2019-2024)
7.4 Global Oral Delivery Vaccines Sales Growth Rate by Application (2019-2024)
8 Oral Delivery Vaccines Market Segmentation by Region
8.1 Global Oral Delivery Vaccines Sales by Region
8.1.1 Global Oral Delivery Vaccines Sales per regio
8.1.2 Wereldwijde orale levering Vaccins Verkoopmarktaandeel per regio
8.2 Noord -Amerika
8.2.1 Noord -Amerika Mondelinge levering Vaccins Verkoop per land
8.2.2 U.S. 8.2.3 Canada
8.2.4 Mexico
8.3 Europe
U.K.
8.3.5 Italië
8.3.6 Rusland
8.4 Asia Pacific
8.4.1 Asia Pacific Oral Delivery Vaccins Verkoop per regio
8.4.2 China
8.4.3 Japan
8.4.4 Zuid -Korea
8.4.5 India
8.4.6 Southeast Asia
South America
South America
South America
South America
8. 5. Brazilië
8.5.3 Argentinië
8.5.4 Columbia
8.6 Midden -Oosten en Afrika
8.6.1 Midden -Oosten en Afrika Orale levering Vaccins Verkoop per regio
8.6.2 Saoedi -Arabië
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key
9 Key Company
9 Key Company
9 Key Company
9 Key Company
9 Key Company
9 Key Company
9 Key Company
9 Key Company
9 Key Company
9 Key Company
9. BR> 9.1 Merck
9.1.1 Merck Oral Delivery Vaccins Basisinformatie
9.1.2 Merck Oral Delivery Vaccines Productoverzicht
9.1.3 Merck Oral Delivery Vaccins Product Market Prestaties
9.1.4 Merck Business Overview
9.1.5 MERCK ORAL LEVERINGSVAVERINGS SWOTS -analyse
9.1.6 Recente ontwikkelingen
9.2 Merck Recente Development
9.2 Merck Recente Development
9.2 Merck Recente Development
9.2 Merck Recente Development
9.2 Recente ontwikkelingen
9.2 GSK
9.2.1 GSK Mondelinge levering Vaccins Basisinformatie
9.2.2 GSK Mondelinge levering Vaccins Productoverzicht
9.2.3 GSK Mondelinge levering Vaccins Productmarktprestaties
9.2.4 GSK BEDRIJFSVOERBIEUW
9.2.5 GSK Orale leverings vaccins SWOT -analyse
9.6 GSK Recente ontwikkelingen
9.3 9.3 9.3. Sanofi
9.3.1 Sanofi Oral Delivery Vaccines Basic Information
9.3.2 Sanofi Oral Delivery Vaccines Product Overview
9.3.3 Sanofi Oral Delivery Vaccines Product Market Performance
9.3.4 Sanofi Oral Delivery Vaccines SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Lanzhou Instituut
9.4.1 Lanzhou Institute Mondelinge levering Vaccins Basisinformatie
9.4.2 LANZHOU Instituut Mondelinge levering Vaccins Productoverzicht
9.4.3 Lanzhou Institute Orale levering Vaccins Productmarktprestaties
9.4.4 Lanzhou Institute Business Overview
9.4.5 LANZHUS RECENTE Development
9.5 Serum Recente ontwikkelingen
9.5 Serum Recente ontwikkelingen
9.5 Serum Recent ontwikkelingen
9.5 Serum. Instituut
9.5.1 Serum Instituut Mondelinge levering Vaccins Basisinformatie
9.5.2 Serum Instituut Mondelinge levering Vaccins Productoverzicht
9.5.3 Serum Instituut Mondeling Vaccins Vaccins Productmarktprestaties
9.5.4 Serum Institute Business Overview
Serum Institute Recente ontwikkelingen
9.6 ValneVa
9.6.6.6.6.6.6.6.6.6.6.6.6.6.6.6.6.6. Vaccines Basic Information
9.6.2 Valneva Oral Delivery Vaccines Product Overview
9.6.3 Valneva Oral Delivery Vaccines Product Market Performance
9.6.4 Valneva Business Overview
9.6.5 Valneva Recent Developments
9.7 Shanghai United Cell
9.7.1 Shanghai United Cell Oral Delivery Vaccines Basic Information
9.7.2 Shanghai United Cell Oral Delivery Vaccines Product Overview
9.7.3 Shanghai United Cell Oral Delivery Vaccines Product Market Performance
9.7.4 Shanghai United Cell Business Overview
9.7.5 Shanghai United Cell Recent Developments
9.8 Bibcol
9.8.1 Bibcol Oral Delivery Vaccines Basic Information
9.8.2 Bibcol Oral Delivery Vaccines Product Overview
9.8.3 Bibcol Oral Delivery Vaccines Product Market Performance
9.8.4 Bibcol Business Overview
9.8.5 Bibcol Recent Developments
9.9 PaxVax
9.9.1 PaxVax Oral Delivery Vaccines Basic Information
9.9.2 PaxVax Oral Delivery Vaccins Productoverzicht
9.9.3 Paxvax Mondelinge levering Vaccins Productmarktprestaties
9.9.4 PAXVAX Zakelijke overzicht
9.9.5 PAXVAX Recente ontwikkelingen
9.10 Vabiotech
9.10.1 VabiTech Oral Delivery Vaccines Basis Informatie
9.10.2 Vabiotech Vaccines Product Overzicht 9.10.4 Vabiotech Business Overview
9.10.5 Vabiotech Recent Developments
9.11 Tiantan Biological
9.11.1 Tiantan Biological Oral Delivery Vaccines Basic Information
9.11.2 Tiantan Biological Oral Delivery Vaccines Product Overview
9.11.3 Tiantan Biological Oral Delivery Vaccines Product Market Performance
9.11.4 Tiantan Biological Business Overview
9.11.5 Tiantan Biological Recent Developments
9.12 EuBiologics
9.12.1 EuBiologics Oral Delivery Vaccines Basic Information
9.12.2 EuBiologics Oral Delivery Vaccines Product Overview
9.12.3 EuBiologics Oral Delivery Vaccines Product Market Prestaties
9.12.4 EUBIODIES Zakelijke overzicht
9.12.5 EUBIOLOGICS RECENTE Developments
9.13 PANACEA BIOTEC LTD
9.13.1 Panacea Biotec Ltd Oral Delivery Vaccins Basisinformatie
9.13.2 PANACEA BIOTEC LTD ORAL LEVERING VACCINES PRODUCTIEVOUDEN
9.13.. LTD Mondelinge levering vaccins Productmarktprestaties
9.13.4 PANACEA BIOTEC LTD BEDRIJFSVOORSVOEG
9.13.5 PANACEA BIOTEC LTD Recente ontwikkelingen
9.14 BIO-MED
9.14.1 Bio-med oral levering vaccins Basis Informatie
9.14.2 Bio-Med Oral Delivery Viccines Product Overzicht
Productoverzicht
PRODUCT-VOCTIEVEWEGEN 9.14.4 BIO-MED Zakelijk overzicht
9.14.5 BIO-MED Recente ontwikkelingen
9.15 Halfkin bio-farmaceuticals
9.15.1 Halfkin bio-pharmaceuticals orale levering vaccins BASCINES BASICES BIO-pharmacuticals. Overzicht
9.15.3 Halfkin bio-farmaceuticals orale levering vaccins productmarktprestaties
9.15.4 Halfkin bio-farmaceuticals bedrijfsoverzicht
9.15.5 Halfkin bio-farmaceuticals recente ontwikkelingen
10 oral levering vaccins markt voorspelling door regio
10.1 Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oral Delivery Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Oral Delivery Vaccines Market Size Forecast by Region
10.2.4 South America Oral Delivery Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oral Delivery Vaccines by Country
11 Forecast Market by Type and per toepassing (2025-2030)
11.1 Marktvoorspelling van de wereldwijde mondelinge levering per type (2025-2030)
11.1.1 Wereldwijde voorspelde vaccins van orale levering vaccins per type (2025-2030)
11.1.2 Globale orale levering Vaccingrootte Via het type (2025-2030) (2025-2030)
11.2 Wereldwijde orale leveringsvaccins Marktvoorspelling per toepassing (2025-2030)
11.2.1 Wereldwijde vaccins Vaccins Vaccins (kilotonen) Voorspelling door toepassing
11.2.2 Wereldwijde orale leveringsvaccins Marktgrootte (M USD) Voorspelling door toepassing (2025-2030)
12 Concluderend en sleutelbevindingen